Cite
HARVARD Citation
Castro, M. et al. (2015). Successful use of next generation genomic sequencing (NGS)-directed therapy of clear cell carcinoma of the ovary (CCCO) with trametinib and metformin in a patient with chemotherapy-refractory disease. Gynecologic oncology research and practice. 2 (1), pp. 1-4. [Online].